Ubique Pharma Private Limited - Company Profile

It is a business services private limited company based in Rajganj, West Bengal, India, established in 2023.
2023 Rajganj, West Bengal, India Active
Last Updated:
Access Report
About Ubique Pharma Private Limited

Ubique Pharma Private Limited, a active private limited company, was established on 09 March 2023 in Rajganj, West Bengal, India. it holds CIN: U47721WB2023PTC260267. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.

Its leadership includes Nisha Barman (Director), Jaya Debsarma Barman (Director), Sashi Debsarma (Ceo). Past directors included Sashi Debsarma. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Papiya Para, Near Naresh More,, P.O. Ghogomali, Bhakti Nagar,, Rajganj, West Bengal, 734006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47721WB2023PTC260267

  • Registration Number

    260267

  • Incorporation Date

    09 March 2023

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.50 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 2 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Ubique Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ubique Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ubique Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nisha Barman Director 09 Mar 2023 Current
Jaya Debsarma Barman Director 09 Mar 2023 Current
Sashi Debsarma Ceo 20 May 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ubique Pharma.

Enhance accessibility to Ubique Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ubique Pharma revenue growth over time
Ubique Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ubique Pharma?

Unlock access to Ubique Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ubique Pharma?

Unlock and access historical data on people associated with Ubique Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ubique Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ubique Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ubique Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ubique Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Ubique Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was completed.

  • Director Appointment

    Sashi Debsarma was appointed as a CEO was appointed as a CEO on 17 Jun 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

  • Director Appointment

    Sashi Debsarma was appointed as a CEO was appointed as a CEO on 20 May 2023 & has been associated with this company since 2 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Nisha Barman was appointed as a Director was appointed as a Director on 09 Mar 2023 & has been associated with this company since 2 years 11 months . was completed.

  • Director Appointment

    The activity Jaya Debsarma Barman was appointed as a Director was appointed as a Director on 09 Mar 2023 & has been associated with this company since 2 years 11 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ubique Pharma Private Limited?

The CIN of Ubique Pharma Private Limited is U47721WB2023PTC260267.

Where is Ubique Pharma Private Limited headquartered?

Ubique Pharma Private Limited is headquartered at Papiya Para, Near Naresh More,, P.O. Ghogomali, Bhakti Nagar,, Rajganj, West Bengal, 734006.

When was Ubique Pharma Private Limited incorporated?

Ubique Pharma Private Limited was incorporated on 09 March 2023.

Who are the current directors of Ubique Pharma Private Limited?

The current directors of Ubique Pharma Private Limited are

Is Ubique Pharma Private Limited a listed company?

Ubique Pharma Private Limited is unlisted.

What is the capital structure of Ubique Pharma Private Limited?

The authorized capital of Ubique Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available